Literature DB >> 9820117

The effect of vaccination against Mycoplasma hypopneumoniae in pig herds with a continuous production system.

D Maes1, H Deluyker, M Verdonck, F Castryck, C Miry, A Lein, B Vrijens, A de Kruif.   

Abstract

An inactivated Mycoplasma hyopneumoniae vaccine was evaluated in five pig herds clinically infected with enzootic pneumonia and practising a continuous production system in the growing/finishing unit. In each herd, a vaccinated and control group of approximately 47 pigs each were individually monitored from birth until slaughter. Vaccinated pigs received the first dose at about 1 week of age and the second approximately 3 weeks later. During all production stages, an equal number of vaccinated and control pigs was present in the same pen. Both groups were compared with respect to zootechnical parameters (major variables) and by means of serological, pathological, and bacteriological parameters (ancillary variables). Daily weight gain was improved by 14 gr/day during the period from 8 days of age until slaughter (P = 0.0486) and by 25 gr/day during the growing/finishing period (P = 0.0067). Mortality rate, and the costs for curative medication were not significantly improved by vaccination. The results of the ancillary variables are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820117     DOI: 10.1111/j.1439-0450.1998.tb00820.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  14 in total

1.  An experimental model to evaluate Mycoplasma hyopneumoniae transmission from asymptomatic carriers to unvaccinated and vaccinated sentinel pigs.

Authors:  Maria Pieters; Eduardo Fano; Carlos Pijoan; Scott Dee
Journal:  Can J Vet Res       Date:  2010-04       Impact factor: 1.310

2.  Experimental evaluation of Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge.

Authors:  SooHwan Kim; Taehwan Oh; Siyeon Yang; Hyejean Cho; Chanhee Chae
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

3.  A Comparative Field Evaluation of the Effect of Growth Performance Between Porcine Circovirus Type 2a (PCV2a)- and PCV2b-Based Bivalent Vaccines Containing PCV2 and Mycoplasma hyopneumoniae.

Authors:  Hyejean Cho; Taehwan Oh; Jeongmin Suh; Chanhee Chae
Journal:  Front Vet Sci       Date:  2022-06-24

4.  Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV.

Authors:  Changhoon Park; Ikjae Kang; Hwi Won Seo; Jiwoon Jeong; Kyuhyung Choi; Chanhee Chae
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

5.  Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae monovalent and bivalent vaccines against a dual challenge.

Authors:  Siyeon Yang; Su-Jin Park; Taehwan Oh; Hyejean Cho; Chanhee Chae
Journal:  Can J Vet Res       Date:  2020-10       Impact factor: 1.310

6.  A field efficacy trial of a trivalent vaccine containing porcine circovirus type 2a and 2b, and Mycoplasma hyopneumoniae in three herds.

Authors:  Hyungmin Um; Siyeon Yang; Taehwan Oh; Hyejean Cho; Kee Hwan Park; Jeongmin Suh; Chanhee Chae
Journal:  Vet Med Sci       Date:  2021-10-22

7.  Transposon mutagenesis in Mycoplasma hyopneumoniae using a novel mariner-based system for generating random mutations.

Authors:  Gareth A Maglennon; Beth S Cook; Alannah S Deeney; Janine T Bossé; Sarah E Peters; Paul R Langford; Duncan J Maskell; Alexander W Tucker; Brendan W Wren; Andrew N Rycroft
Journal:  Vet Res       Date:  2013-12-21       Impact factor: 3.683

8.  A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.

Authors:  Panagiotis D Tassis; Ioannis Tsakmakidis; Vassileios G Papatsiros; Dimitrios Koulialis; Tom Nell; Georgia Brellou; Eleni D Tzika
Journal:  BMC Vet Res       Date:  2017-04-07       Impact factor: 2.741

9.  Effectiveness of two intramuscular combined vaccines for the control of Mycoplasma hyopneumoniae and porcine circovirus type 2 in growing pigs: a randomized field trial.

Authors:  Gwenaël Boulbria; Sophie Brilland; Charlotte Teixeira-Costa; Mathieu Brissonnier; Mathieu Charles; Nathalie Capdevielle; Valérie Normand; Franck Bouchet; Pauline Berton; Roman Krejci; Arnaud Lebret
Journal:  Porcine Health Manag       Date:  2021-06-27

10.  Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs.

Authors:  Ioannis Arsenakis; Luca Panzavolta; Annelies Michiels; Rubén Del Pozo Sacristán; Filip Boyen; Freddy Haesebrouck; Dominiek Maes
Journal:  BMC Vet Res       Date:  2016-03-29       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.